Halovate F Cream is a topical formulation containing Halobetasol propionate 0.05% w/w, a potent corticosteroid, combined with Fusidic Acid 2% w/w, a bacteriostatic antibiotic. This combination is indicated for the treatment of inflammatory dermatoses complicated by secondary bacterial infections, such as eczema, psoriasis, and dermatitis. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting the release of inflammatory mediators and suppressing immune responses, thereby reducing redness, swelling, and itching. Fusidic Acid acts by inhibiting bacterial protein synthesis, effectively targeting gram-positive bacteria including Staphylococcus aureus, which commonly colonize or infect inflamed skin lesions. Halovate F Cream should be applied in a thin layer to the affected area once or twice daily as directed by a healthcare professional. Treatment duration is generally limited to avoid potential corticosteroid-related adverse effects such as skin atrophy, striae, and systemic absorption. Caution is advised in patients with known hypersensitivity to any component, and it is contraindicated in viral, fungal, or tuberculosis skin infections. Use during pregnancy and lactation should be under medical supervision. Proper hygiene and adherence to prescribed usage optimize therapeutic outcomes and minimize resistance development.